The filing is a routine insider intent-to-sell notice with no material financial impact. Monitor for any subsequent Form 4 filings to confirm execution and for any pattern of insider selling that could indicate changing sentiment.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $20.65entry
- T+1 · 6d ago +0.19%α −1.46% · $20.69
- T+5 · 12h ago +12.74%α +13.32% · $23.28
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Director Kapil Dhingra filed a Form 144 notice of intent to sell 16,500 shares of Replimune Group common stock, with an estimated aggregate market value of $292,875 based on a $17.75 per share reference price. The sale is planned for November 2, 2026, and the shares were acquired through stock option exercises. The filing signals insider intent to monetize equity, but the relatively small size relative to the company's $1.6B market cap limits the signal's magnitude.
Key Facts
- Insider Kapil Dhingra (Director) filed Form 144 to sell 16,500 shares of REPL common stock.
- Estimated aggregate market value of the proposed sale is $292,875.
- Shares were acquired via stock option exercise on the same date (11/02/2026).
- The sale is planned for execution on 11/02/2026 through J.P. Morgan Securities LLC.
- The proposed sale represents approximately 0.018% of the company's $1.6B market cap.
Financial Impact
Proposed sale of 16,500 shares valued at $292,875, a de minimis amount relative to the $1.6B market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed.
- Insider selling could be misinterpreted as a lack of confidence, but the small size relative to market cap limits concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001968582-26-001089 |
| Document: 0001968582-26-001089-index.html | 0001968582-26-001089 |
| Document: 0001968582-26-001089.txt | 0001968582-26-001089 |
Track record
31 reports on REPL
9 of 13 bullish or bearish reports moved the stock their way by T+60. Best: +188.35% at T+20 after the Jul 30, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 10, 2026today Insider Cluster Neutral 2/10 Entry $23.47 Now $23.28 −0.81% settles Feb 9
- Nov 10, 2026today SC 13G Neutral 3/10 Entry $22.00 Now $23.28 +5.82% settles Feb 8
- Nov 9, 20261d ago 144 Neutral 2/10 Entry $22.51 Now $23.28 +3.42% settles Feb 8
- Nov 9, 20261d ago SC 13G/A Neutral 2/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
- Nov 6, 20264d ago 10-Q/A Neutral 3/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
- Nov 4, 20266d ago Institutional Cluster Bearish 4/10 Entry $20.69 Now $23.28 −12.52% settles Feb 2
- Nov 3, 20267d ago 144 Neutral 2/10 Entry $20.69 Now $23.28 +12.52% settles Feb 2
- Nov 2, 20268d ago 144 Neutral 2/10 Viewing Entry $20.65 Now $23.28 +12.74% settles Feb 1
- Oct 30, 202611d ago 144 Neutral 2/10 Entry $19.49 Now $23.28 +19.45% settles Jan 29
- Oct 28, 202613d ago 144 Neutral 2/10 Entry $17.39 Now $23.28 +33.87% settles Jan 27
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers